<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>PREGNYLÂ - choriogonadotropin alfaÂ 
			Â </strong><br>Physicians Total Care, Inc.<br></p></div>
<h1>Pregnyl<span class="Sup">Â®</span><br>(chorionic gonadotropin for injection, USP)</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="INV-f1c7c986-f12c-47df-b44c-a6359d5094e2"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Human chorionic                             gonadotropin (HCG), a polypeptide hormone produced by the human                             placenta, is composed of an alpha and a beta sub-unit. The alpha                             sub-unit is essentially identical to the alpha sub-units of the human                             pituitary gonadotropins, luteinizing hormone (LH) and                             follicle-stimulating hormone (FSH), as well as to the alpha sub-unit of                             human thyroid-stimulating hormone (TSH). The beta sub-units of these                             hormones differ in amino acid sequence.</p>
<p>PREGNYLÂ®                             (chorionic gonadotropin for injection, USP) is a highly purified                             pyrogen-free preparation obtained from the urine of pregnant females. It                             is standardized by a biological assay procedure. It is available for                             intramuscular injection in multiple dose vials containing 10,000 USP                             Units of sterile dried powder with 5 mg monobasic sodium phosphate and                             4.4 mg dibasic sodium phosphate. If required, pH is adjusted with sodium                             hydroxide and/or phosphoric acid. Each package also contains a 10 mL                             vial of solvent containing: water for injection with 0.56% sodium                             chloride and 0.9% BENZYL ALCOHOL, WHICH IS NOT FOR USE IN NEWBORNS. If                             required, pH is adjusted with sodium hydroxide and/or hydrochloric                         acid.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="INV-e00d2a06-e3a5-4b5f-b61b-15ced7703cd2"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">The action of HCG                             is virtually identical to that of pituitary LH, although HCG appears to                             have a small degree of FSH activity as well. It stimulates production of                             gonadal steroid hormones by stimulating the interstitial cells (Leydig                             cells) of the testis to produce <span class="product-label-link" type="condition" conceptid="4233066" conceptname="Androgen level">androgens</span> and the corpus luteum of the                             ovary to produce progesterone.</p>
<p>Androgen                             stimulation in the male leads to the development of secondary sex                             characteristics and may stimulate testicular descent when no anatomical                             impediment to descent is present. This descent is usually reversible                             when HCG is discontinued.</p>
<p>During the normal                             menstrual cycle, LH participates with FSH in the development and                             maturation of the normal ovarian follicle, and the mid-cycle LH surge                             triggers ovulation. HCG can substitute for LH in this function. During a                             <span class="product-label-link" type="condition" conceptid="4128331" conceptname="Pregnancy">normal pregnancy</span>, HCG secreted by the placenta maintains the corpus                             luteum after LH secretion decreases, supporting continued secretion of                             estrogen and progesterone and preventing menstruation. HCG HAS NO KNOWN                             EFFECT ON FAT MOBILIZATION, APPETITE OR SENSE OF <span class="product-label-link" type="condition" conceptid="4205415" conceptname="Hungry">HUNGER</span>, OR BODY FAT                             DISTRIBUTION.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="INV-b20428b6-4ead-43a7-8b2f-6dc1fd1d5c64"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">HCG HAS NOT BEEN                             DEMONSTRATED TO BE EFFECTIVE ADJUNCTIVE THERAPY IN THE TREATMENT OF                             <span class="product-label-link" type="condition" conceptid="433736" conceptname="Obesity">OBESITY</span>. THERE IS NO SUBSTANTIAL EVIDENCE THAT IT INCREASES <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">WEIGHT LOSS</span>                             BEYOND THAT RESULTING FROM CALORIC RESTRICTION, THAT IT CAUSES A MORE                             ATTRACTIVE OR â€œNORMALâ€? DISTRIBUTION OF FAT, OR THAT                             IT DECREASES THE <span class="product-label-link" type="condition" conceptid="4205415" conceptname="Hungry">HUNGER</span> AND <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">DISCOMFORT</span> ASSOCIATED WITH                             CALORIE-RESTRICTED DIETS.</p>
<ol class="Arabic">
<li>Prepubertal <span class="product-label-link" type="condition" conceptid="437655" conceptname="Undescended testicle">cryptorchidism</span> not due to anatomical obstruction. In                                 general, HCG is thought to induce testicular descent in situations                                 when descent would have occurred at puberty. HCG thus may help                                 predict whether or not orchiopexy will be needed in the future.                                 Although, in some cases, descent following HCG administration is                                 permanent, in most cases, the response is temporary. Therapy is                                 usually instituted in children between the ages of 4 and 9.</li>
<li>Selected cases of hypogonadotropic <span class="product-label-link" type="condition" conceptid="4167354" conceptname="Hypogonadism">hypogonadism</span> (<span class="product-label-link" type="condition" conceptid="4167354" conceptname="Hypogonadism">hypogonadism</span>                                 secondary to a pituitary deficiency) in males.</li>
<li>Induction of ovulation and pregnancy in the anovulatory, infertile                                 woman in whom the cause of <span class="product-label-link" type="condition" conceptid="4144685" conceptname="Anovulation">anovulation</span> is secondary and not due to                                 <span class="product-label-link" type="condition" conceptid="193739" conceptname="Ovarian failure">primary ovarian failure</span>, and who has been appropriately pretreated                                 with human menotropins.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="INV-22381c09-aaf6-48fd-a064-228129d7f70e"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4267558" conceptname="Precocious puberty">Precocious puberty</span>,                             prostatic carcinoma or other androgen-dependent neoplasm, prior allergic                             reaction to HCG.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="INV-9c866d49-e7b4-48b5-a003-d7ebc6b7afcf"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">HCG should be used                             in conjunction with human menopausal gonadotropins only by physicians                             experienced with <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">infertility</span> problems who are familiar with the criteria                             for patient selection, contraindications, warnings, precautions, and                             adverse reactions described in the package insert for menotropins.</p>
<p><span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">Anaphylaxis</span> has been reported with urinary-derived HCG products.</p>
<p>The principal serious adverse reactions during this use are:<br>(1) <span class="product-label-link" type="condition" conceptid="4305298" conceptname="Ovarian hyperstimulation syndrome">Ovarian hyperstimulation</span>, a syndrome of sudden <span class="product-label-link" type="condition" conceptid="4281817" conceptname="Large ovary">ovarian enlargement</span>, <span class="product-label-link" type="condition" conceptid="200528" conceptname="Ascites">ascites</span> with or without <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, and/or <span class="product-label-link" type="condition" conceptid="254061" conceptname="Pleural effusion">pleural effusion</span>,  (2) Rupture of <span class="product-label-link" type="condition" conceptid="193530" conceptname="Follicular cyst of ovary">ovarian cysts</span> with resultant <span class="product-label-link" type="condition" conceptid="194690" conceptname="Nontraumatic hemoperitoneum">hemoperitoneum</span>, (3) Multiple births, and (4) Arterial <span class="product-label-link" type="condition" conceptid="4159647" conceptname="Thromboembolic disorder">thromboembolism</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="INV-8e70533b-388a-40f2-942b-47430c76b7c1"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="INV-c8f1d1ec-ee0a-4f3f-b181-badf552a0bfe"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">Since                                     <span class="product-label-link" type="condition" conceptid="4233066" conceptname="Androgen level">androgens</span> may cause <span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">fluid retention</span>, HCG should be used with                                     caution in patients with cardiac or <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>, <span class="product-label-link" type="condition" conceptid="380378" conceptname="Epilepsy">epilepsy</span>,                                     <span class="product-label-link" type="condition" conceptid="318736" conceptname="Migraine">migraine</span>, or <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="INV-ddb69378-dbe9-4d0d-86ef-d293ff4884ba"></a><a name="section-6.2"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Induction                                     of androgen secretion by HCG may induce <span class="product-label-link" type="condition" conceptid="4267558" conceptname="Precocious puberty">precocious puberty</span> in                                     pediatric patients treated for <span class="product-label-link" type="condition" conceptid="437655" conceptname="Undescended testicle">cryptorchidism</span>. Therapy should be                                     discontinued if signs of <span class="product-label-link" type="condition" conceptid="4267558" conceptname="Precocious puberty">precocious puberty</span> occur.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="INV-8bafa125-3191-4e5f-b091-1532e59455b4"></a><a name="section-6.3"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical                                     studies of PREGNYLÂ® (chorionic gonadotropin for                                     injection, USP) did not include subjects aged 65 and                                 over.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="INV-80bee88f-d8d8-4d79-9697-dab0a135dd90"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span>,                             <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, precocious                             puberty, <span class="product-label-link" type="condition" conceptid="4168447" conceptname="Gynecomastia">gynecomastia</span>, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> at the site of injection.</p>
<p><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span>, both localized and systemic in nature, have been reported.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="INV-4b8c7ab7-df8a-4789-be86-6c5517fea19c"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">For intramuscular                             use only. The dosage regimen employed in any particular case will depend                             upon the indication for the use, the age and weight of the patient, and                             the physicianâ€™s preference. The following regimens have been                             advocated by various authorities:</p>
<p><span class="Italics">Prepubertal <span class="product-label-link" type="condition" conceptid="437655" conceptname="Undescended testicle">cryptorchidism</span> not due to                                 anatomical obstruction. Therapy is usually instituted in children                                 between the ages of 4 and 9.</span></p>
<ol class="Arabic">
<li>4,000 USP Units three times weekly for three weeks.</li>
<li>5,000 USP Units every second day for four injections.</li>
<li>15 injections for 500 to 1,000 USP Units over a period of six                                 weeks.</li>
<li>500 USP Units three times weekly for four to six weeks. If this                                 course of treatment is not successful, another series is begun one                                 month later, giving 1,000 USP Units per injection.</li>
</ol>
<p><span class="Italics">Selected cases of hypogonadotropic                                 <span class="product-label-link" type="condition" conceptid="4167354" conceptname="Hypogonadism">hypogonadism</span> in males.</span></p>
<ol class="Arabic">
<li>500 to 1,000 USP Units three times a week for three weeks,                                 followed by the same dose twice a week for three weeks.</li>
<li>4,000 USP Units three times weekly for six to nine months,                                 following which the dosage may be reduced to 2,000 USP Units three                                 times weekly for an additional three months.</li>
</ol>
<p><span class="Italics">Induction of ovulation and pregnancy in the                                 anovulatory, infertile woman in whom the cause of <span class="product-label-link" type="condition" conceptid="4144685" conceptname="Anovulation">anovulation</span> is                                 secondary and not due to <span class="product-label-link" type="condition" conceptid="193739" conceptname="Ovarian failure">primary ovarian failure</span> and who has been                                 appropriately pretreated with human menotropins.</span></p>
<p>(See prescribing                             information for menotropins for dosage and administration for that drug                             product.)</p>
<p>5,000 to 10,000 USP                             Units one day following the last dose of menotropins. (A dosage of                             10,000 USP Units is recommended in the labeling for                         menotropins.)</p>
<div class="Section">
<a name="INV-b873786b-653c-4212-bcfe-6799bdbf540a"></a><a name="section-8.1"></a><p></p>
<h2>Directions for                                 Reconstitution</h2>
<p class="First">Two-vial                                     package: Withdraw sterile air from lyophilized vial and inject                                     into diluent vial. Remove 1â€“10 mL from diluent and add                                     to lyophilized vial; agitate gently until powder is completely                                     dissolved in solution.</p>
<p>Parenteral                                     drug products should be inspected visually for particulate                                     matter and discoloration prior to administration, whenever                                     solution and container permit.</p>
<p><span class="Bold">IMPORTANT: USE COMPLETELY AFTER                                         RECONSTITUTION. RECONSTITUTED SOLUTION IS STABLE FOR 60 DAYS                                         WHEN REFRIGERATED.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="INV-a0c9926e-00f8-46fc-b902-72f6c733c82a"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Two-vial package                             containing:</p>
<p>1-10 mL lyophilized                             multiple dose vial containing: 10,000 USP Units chorionic gonadotropin                             per vial, NDC 54868-4997-0.</p>
<p>1-10 mL vial of                             solvent containing: water for injection with sodium chloride 0.56% and                             benzyl alcohol 0.9%, <br></p>
<p>When reconstituted,                             each 10 mL vial contains:</p>
<a name="INV-0db519a3-eb5a-45f0-9e6d-8d02646bcbc1"></a><table>
<col align="left">
<col align="left">
<tbody class="Headless">
<tr class="First">
<td align="left">Chorionic gonadotropin</td>
<td align="left">10,000 USP Units</td>
</tr>
<tr>
<td align="left">Monobasic sodium phosphate</td>
<td align="left">5 mg</td>
</tr>
<tr>
<td align="left">Dibasic sodium phosphate</td>
<td align="left">4.4 mg</td>
</tr>
<tr>
<td align="left">Sodium chloride</td>
<td align="left">0.56%</td>
</tr>
<tr class="Last">
<td align="left">Benzyl alcohol</td>
<td align="left">0.9%</td>
</tr>
</tbody>
</table>
<p>If required pH                             adjusted with sodium hydroxide and/or phosphoric acid.</p>
<div class="Section" data-sectionCode="44425-7">
<a name="INV-777e4811-7534-4b98-a6e3-ad34cdfd64cc"></a><a name="section-9.1"></a><p></p>
<h2>Storage</h2>
<p class="First">Store at controlled room temperature 15â€“30Â°C (59â€“86Â°F).                                  Reconstituted solution is stable for 60 days when refrigerated.</p>
<p><span class="Bold">Rx Only</span></p>
<p>Manufactured for</p>
<p>Organon USA                                     Inc. Roseland, NJ 07068</p>
<p>by Baxter                                     Pharmaceutical Solutions LLC</p>
<p>Bloomington, IN 47403</p>
<p>Â©2006 Organon USA Inc.</p>
<p>Rev. 4/11 <br><span class="Bold">35039007T</span></p>
<p><br><span class="Bold"></span></p>
<p><br><span class="Bold"></span></p>
<p><span class="Bold">Additional barcode labeling by:</span><br>Physicians Total Care, Inc.<br>Tulsa, OklahomaÂ Â Â Â Â Â  74146<br></p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-10"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 10,000 USP Units/Vial Carton</h1>
<p class="First"><span class="Bold">NDC</span> 54868-4997-0</p>
<p><img alt="PRINCIPAL DISPLAY PANEL - 10,000 USP Units/Vial Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dc604794-6dd6-43a7-85fa-2f04ed325c33&amp;name=4997.jpg"></p>
<p>10 mL multidose vial<br>with 10 mL vial of solvent</p>
<p><span>Pregnyl<span class="Sup">Â®</span></span><br>(chorionic gonadotropin<br>for injection, USP)</p>
<p><span class="Bold">10,000<br>USP Units/vial</span></p>
<p><span class="Bold">For Intramuscular<br>Injection Only</span></p>
<p><span class="Bold">Rx only</span></p>
<br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PREGNYLÂ 		
					</strong><br><span class="contentTableReg">choriogonadotropin alfa kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54868-4997(NDC:0052-0315)</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54868-4997-0</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">PartÂ #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 VIAL, MULTI-DOSE </td>
<td class="formItem">10Â mL</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 VIAL </td>
<td class="formItem">10Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>PREGNYLÂ 		
					</strong><br><span class="contentTableReg">choriogonadotropin alfa injection, powder, lyophilized, for solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAMUSCULAR</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>CHORIOGONADOTROPIN ALFA</strong> (CHORIOGONADOTROPIN ALFA) </td>
<td class="formItem">CHORIOGONADOTROPIN ALFA</td>
<td class="formItem">10000Â [USP'U] Â inÂ 10Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM PHOSPHATE, MONOBASIC</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM PHOSPHATE, DIBASIC</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PHOSPHORIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017692</td>
<td class="formItem">02/18/2004</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>PREGNYL SOLVENTÂ 		
					</strong><br><span class="contentTableReg">water, sodium chloride and benzyl alcohol injection, solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAMUSCULAR</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">10 mL in 1 VIAL</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017692</td>
<td class="formItem">02/18/2004</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017692</td>
<td class="formItem">08/17/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Physicians Total Care, Inc.
							(194123980)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Physicians Total Care, Inc.</td>
<td class="formItem"></td>
<td class="formItem">194123980</td>
<td class="formItem">relabel</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>10e409a4-8539-43f5-9081-ec58e3cbda65</div>
<div>Set id: dc604794-6dd6-43a7-85fa-2f04ed325c33</div>
<div>Version: 1</div>
<div>Effective Time: 20120419</div>
</div>
</div>Â <div class="DistributorName">Physicians Total Care, Inc.</div></p>
</body></html>
